APA

Tomita Y., Fukasawa S., Oya M., Uemura H., Shinohara N., Habuchi T., Rini B. I., Chen Y., Bair A. H., Ozono S., Naito S. & Akaza H. (2016). Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study. : Japanese journal of clinical oncology.

Chicago

Tomita Yoshihiko, Fukasawa Satoshi, Oya Mototsugu, Uemura Hirotsugu, Shinohara Nobuo, Habuchi Tomonori, Rini Brian I, Chen Ying, Bair Angel H, Ozono Seiichiro, Naito Seiji and Akaza Hideyuki. 2016. Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study. : Japanese journal of clinical oncology.

Harvard

Tomita Y., Fukasawa S., Oya M., Uemura H., Shinohara N., Habuchi T., Rini B. I., Chen Y., Bair A. H., Ozono S., Naito S. and Akaza H. (2016). Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study. : Japanese journal of clinical oncology.

MLA

Tomita Yoshihiko, Fukasawa Satoshi, Oya Mototsugu, Uemura Hirotsugu, Shinohara Nobuo, Habuchi Tomonori, Rini Brian I, Chen Ying, Bair Angel H, Ozono Seiichiro, Naito Seiji and Akaza Hideyuki. Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study. : Japanese journal of clinical oncology. 2016.